Research opportunities in early detection and diagnosis
More…
More…
More…
More…
We have a broad variety of opportunities to help researchers progress their early detection and diagnosis research or get involved in this field for the first time, from research funding grants to events and conferences.
We support research across the pipeline, from discovery research which takes us further in our understanding of early-stage disease, to translational studies and research which bridges the gap between scientific breakthroughs and clinical practice or healthcare policies.
Our ambition is to accelerate progress so that 3 in 4 patients survive cancer by 2034. We believe earlier diagnosis offers the greatest potential for transformational improvements in patient outcomes.
To achieve our ambitions, we will:
We have a range of funding opportunities catering for researchers at all career stages and in any research field which can impact on earlier detection and diagnosis of cancer, from large-scale programme funding to individual project grants and personal fellowships.
Our Research Funding Managers can help you find the right funding for your circumstances, and guide you through the application process.
Our events break the barriers between disciplines and open up new avenues for collaborative research. We have upcoming conferences in early detection and early diagnosis, as well as online archives of highlights and outputs from previous events.
We’re hosting a series of networking events to foster collaborations between academia and industry. The first is a collaboration with Innovate UK’s Knowledge Transfer Network (KTN) and will focus on in vitro diagnostics. The event will be held in the lead up to our new Primer Award, which funds novel collaborations.
25 January 2019
London
Our annual early detection conference brings together world experts across a range of disciplines to discuss themes including the biology behind early-stage cancers, new detection and screening methods, and enhancing the accuracy and uptake of screening.
24-26 September 2019
Stanford, California
Our biannual early diagnosis research conference explores research on the diagnostic pathway, including screening, public awareness of symptoms and factors in the primary and secondary care systems.
Spring 2019
TBC
We fund the best research from the best researchers, across the spectrum of early detection and early diagnosis research. The case studies below provide a taste of the kinds of projects and programmes that we support.
We’ve made an ambitious commitment to invigorate early detection research by stimulating research interest, building capacity, forging new partnerships, and actively supporting a community for early detection research.
Our Catalyst Award is building capacity for a step change in population research, and has funded its first programme: CanTest – offering patients the right test, at the right time, and in the right setting.
EDAG funds policy-relevant research or activities that are adding to the scientific evidence base to achieve earlier diagnosis and enable access to treatment.
We’re partnering with the OHSU Knight Cancer Institute, a world leader in precision cancer medicine, to accelerate progress by identifying and tackling the barriers to earlier detection.
Dr Jelle Wesseling is leading an international team seeking to understand which women with DCIS will develop breast cancer, in a £15 million partnership with the Dutch Cancer Society.
Dr Sarah Bohndiek, a physicist at our CRUK Cambridge Institute, is investigating new technologies for detecting oesophageal cancer cells earlier.
Professor Rebecca Fitzgerald, a clinician scientist at our CRUK Cambridge Centre, is trialling Cytosponge, a new device that could accelerate the detection of oesophageal cancer and its precursor, Barrett’s oesophagus.
Professor Caroline Dive at our CRUK Manchester Institute is using cutting-edge technology to analyse circulating tumour cells in a collaboration with the US Cancer Moonshot initiative.
We’re working with Abcodia, the biomarker validation company, to develop new blood tests to detect a range of cancers, combining our complementary strengths and drawing new value from our unrivaled sample collections.
Our long-term investment in state-of-the-art facilities helps to support a thriving network of research around the UK. Our network includes four core-funded Institutes, home to world-class discovery research, and translational Centres which build collaboration with the UK’s healthcare system to ensure our research benefits patients sooner. We have particular strengths in early detection and diagnosis research at our Centres and Institutes in Cambridge and Manchester.
Our infrastructure is open for collaboration and partnerships, and provides many opportunities for you to progress your research.
In 2018, we teamed up with the Academy of Medical Sciences to address the challenges facing emerging early detection and diagnosis approaches and technologies. Our report outlines changes which could accelerate translational research and the implementation of early detecton and diagnosis approaches and technologies in the healthcare system.
We have a number of newsletters to help you stay up to date with developments in early detection and diagnosis, and with new research opportunities.
We work to ensure that diagnosing cancer early stays at the top of the agenda, and that research discoveries translate into healthcare policies and clinical practice in the NHS.
Find out about activities in the UK focusing on early diagnosis of cancer, including screening projects and resources, and our early diagnosis research conferences.
Our scientists are looking at new ways to detect cancers earlier, and we’ve contributed to some of the advances that have seen cancer survival rates double over the past 40 years.
Research opportunities in early detection and diagnosis
Research & References of Research opportunities in early detection and diagnosis|A&C Accounting And Tax Services
Source
0 Comments